Cencora, Inc.

Cencora (COR) Remains Attractive Despite Temporary Headwinds

Carillon Tower Advisers, an investment management company, released its second-quarter 2026 investor letter for the “Carillon Eagle Mid Cap Growth Fund”. A copy of the letter is available to download here. Mid-cap stocks delivered strong results, with the Russell Midcap® Growth Index rising 14.55% and slightly outperforming the Russell Midcap® Value Index’s 13.40% gain. Information […]

Yahoo Finance · 31/07/2026 · lire l'article ↗

Countdown to Cencora (COR) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Beyond analysts' top-and-bottom-line estimates for Cencora (COR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.

Yahoo Finance · 31/07/2026 · lire l'article ↗

Good Neighbor Pharmacy® Named #1 in Customer Satisfaction with Chain Drug Store Pharmacies and Most Trusted by JD Power

CONSHOHOCKEN, Pa., July 29, 2026--Good Neighbor Pharmacy, a national franchise for independent pharmacies offered through Cencora, has been ranked "#1 in Customer Satisfaction with Chain Drug Store Pharmacies" in the JD Power 2026 U.S. Pharmacy StudySM, a syndicated benchmarking study profiling the experiences of customers of the largest pharmacies in the United States. In addition to ranking highest overall, Good Neighbor Pharmacy ranked highest across four of seven dimensions: Pharmacy offerin

Yahoo Finance · 29/07/2026 · lire l'article ↗

Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo Finance · 29/07/2026 · lire l'article ↗

Is Cencora (COR) Still Trading At A Discount As Its P E Rerating Gains Pace?

Recent screening for stocks with rising P/E ratios and consistent price gains relative to the S&P 500 has put Cencora (COR) in focus for investors tracking valuation and earnings expectations. See our latest analysis for Cencora. Cencora’s recent screening attention comes after a generally mixed year for the share price, with a 30 day share price return of 8.94% contrasting with a year to date decline of 8.55% and a 1 year total shareholder return of 7.53%. This suggests longer term holders...

Yahoo Finance · 25/07/2026 · lire l'article ↗

Cencora (COR) Stock Looks Undervalued As Its 167% Five Year Return Builds

Cencora stock has delivered a strong 167.1% return over the past 5 years, yet its current valuation still screens as cheap. An intrinsic value estimate from a Discounted Cash Flow (DCF) model suggests the shares trade at a meaningful discount to that estimate, while market multiples also lean toward an undervalued verdict. A 167.1% total return over 5 years sets a high bar for Cencora. Any hint that cash flow growth slows or that returns on capital plateau may make the current valuation...

Yahoo Finance · 25/07/2026 · lire l'article ↗